GLP1R and diabetes mellitus: The joint recommendations from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) suggest metformin as the first-line drug in glycemic management and the use of GLP-1 RA and SGLT2is with proven benefits in high-risk patients [17].